Delivery Order SPE2DB22D9353-SPE2DB25FX2EY
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $29.3K by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025. The contract calls for delivery of EYLEA 2 mg/0.05 ml syringes, a prescribed pharmaceutical product used primarily for treating age-related macular degeneration and other retinal conditions. Performance is scheduled for completion by...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $19,812.70 by the Defense Logistics Agency (DLA) on September 15, 2025. The delivery order covers the supply of EYLEA HD 8 mg/0.07 mL vials, a prescription pharmaceutical product, with an ultimate completion date of October 6, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,940.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, which has a completion date of July 18, 2024, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product used to treat certain medical conditions. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of EYLEA 2 mg/0.05 ml vials totaling $25,135.40. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA. The award carries...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,943.78 by the Defense Logistics Agency on July 31, 2025. The contract calls for delivery of EYLEA HD 8 mg/0.07 ml vials, a pharmaceutical product used to treat eye conditions, with an ultimate completion date of August 21, 2025. The award was issued without a set-aside designation and specifies Park Ridge, Illinois as...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $198,126 by the Defense Logistics Agency on August 19, 2025. The delivery order is for EYLEA HD 8 mg/0.07 ml vial medication, with an ultimate completion date of September 10, 2025. This award carries no set-aside designation, allowing the vendor to compete on an unrestricted basis despite its small business status. The place...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $29.3 thousand by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. The contract covers the delivery of EYLEA 2 mg/0.05 ml syringes to support federal healthcare requirements, with an ultimate completion date of August 18, 2025. This delivery order was issued without a set-aside designation and is...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $29.3K on September 2, 2025, by the Defense Logistics Agency's Medical Supply Chain organization. The delivery order, which carries no set-aside designation, covers the supply of EYLEA 2 mg/0.05 ml syringes for delivery to Park Ridge, Illinois, with an ultimate completion date of September 23, 2025. EYLEA is a prescription...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $54,016.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which runs through December 31, 2025. The delivery order is for the pharmaceutical product EYLEA 2 MG/0.05 ML VIAL 0.05ML, with a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,667.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on July 30, 2025, is scheduled for ultimate completion by August 20, 2025, with performance taking place in Park Ridge, Illinois. The contract carries no set-aside designation, allowing DMS Pharmaceutical...
- SPE2DB22D9353Indefinite Delivery Contract
- SPE2DB22D9353-SPE2DB25FX2EYDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $44,002.80 by the Defense Logistics Agency (DLA) on September 17, 2025. The delivery order, which carries no set-aside designation, covers the supply of EYLEA 2 mg/0.05 ml syringes, a prescription pharmaceutical product used in the treatment of wet age-related macular degeneration and other retinal conditions. The award is expected to be completed by October 8, 2025, with the place of performance located in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for an extensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. As a established supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated consistent capability in delivering branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.0k | 9/17/25 |